Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: utility of population analysis.
Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: utility of population analysis. Cancer Invest. 2001; 19(1):57-64.